Commentary: America’s Electoral System Is Suffering from a Credibility Crisis

Defying all predictions of a photo finish senate race, Pennsylvania Democrat John Fetterman won 50.3% of the vote to Republican Dr. Mehmet Oz’s 47.3%. The unexpectedly large margin helped avoid a midterm meltdown. But don’t be deceived; that margin masks major electoral system dysfunction that remains unaddressed.

If the margins had been narrower, things might have looked very different. Democratic Gov. Tom Wolf last year vetoed a commonsense measure that would have modernized Pennsylvania’s Depression-era voting laws. As a result, the Commonwealth is saddled with a ponderous mail voting system bolted onto a rickety election code that forbids routine practices like voter ID and pre-processing mail ballots. Those policies secure elections and speed tabulations, but were vetoed by Wolf last year.

Read More

Pennsylvania GOP Senate Race May Not See Winner Until June

The Pennsylvania Republican Senate primary is still too close to call and likely headed for a recount which could delay the declaration of a winner into mid-June.

Per the Associated Press, Dr. Mehmet Oz currently holds a narrow 1,079 vote lead over rival David McCormick, amounting to 0.08% of the 1,340,248 total votes.

Read More

John Fredericks Hosts Trump-Endorsed GOP Senate Hopeful Dr. OZ at Bristol, Pennsylvania Townhall

Neil W. McCabe, the national political editor of The Star News Network, covered the April 20, 2022, Bristol, Pennsylvania., townhall, featuring GOP Senate hopeful Dr. Mehmet Oz and former Housing and Urban Development head Dr. Ben Carson, which was hosted by talk radio’s ‘Godzilla of Truth’ John Fredericks.

Read More

Dr. Oz’s Ties to Pharma, Tech Complicate Anti-Corporate Campaign Claims

While Republican Pennsylvania Senate candidate Dr. Mehmet Oz has billed himself as a staunch opponent of big corporations, his ties to major technology and pharmaceutical corporations complicate his campaign rhetoric.

Oz, who announced his candidacy in late November, is running for the empty Senate seat left by retiring Republican Pennsylvania Sen. Pat Toomey. The celebrity doctor has made opposition to major technology and pharmaceutical companies a hallmark of his campaign, pitching his experience working in television and exposing scams as an example of his anti-corporate positions.

Read More